A new treatment is giving deaf patients the chance to hear

Date:

Share this article:

Del denne artikel:

A single gene therapy injection is now showing early signs that hearing loss may no longer be permanent for some patients.

Sound is something most people rarely think about. A voice, a laugh, a passing car — it all blends into everyday life without effort.

But for those born without hearing, that world is silent. And for years, treatment options have been limited, often focusing on managing rather than restoring.

Now, new research suggests that may be starting to change, according to Science Daily.

A breakthrough trial

Scientists at Karolinska Institutet, working with several hospitals in China, have tested a new form of gene therapy aimed at restoring hearing in people born deaf.

Also read: How swallowing gum can affect the body

The study, published in Nature Medicine, involved ten patients aged between 1 and 24, all with a genetic condition linked to the OTOF gene.

This gene plays a key role in transmitting sound signals from the inner ear to the brain. When it does not function properly, hearing is severely impaired from birth.

Fast improvements

Instead of long-term treatment, researchers used a single injection to deliver a healthy version of the gene directly into the inner ear.

The results appeared quickly. Many participants began to detect sound within weeks, and after six months all showed clear improvement.

Also read: Doctor raises concerns over cereals and juice as a daily breakfast

On average, hearing ability improved significantly, moving from levels associated with profound hearing loss to ranges where speech becomes more accessible.

Younger patients experienced the most noticeable changes, but adults also showed meaningful progress.

What comes next

The treatment was generally well tolerated, with no serious side effects reported during the follow-up period.

Researchers now see this as an early step toward broader genetic treatments for hearing loss.

Also read: New drug shows promise for patients with high blood pressure

Key points from the study:

  • A single injection was enough to trigger improvement
  • Effects appeared within weeks for many patients
  • Both children and adults responded to treatment

Future work will explore similar therapies targeting other genes linked to deafness, which could expand the impact of this approach.

Also read: These nail changes may indicate underlying heart or liver conditions

This article is made and published by Mie Hermansen, who may have used AI in the preparation.

Other articles

Why you should always look for ‘D3’ on your vitamin supplement

The two forms on the shelf look almost identical, but new research suggests one may quietly work against the other.

8 warning signs of chronic kidney disease most people write off as something else

Your kidneys can quietly lose most of their work before you ever feel anything is wrong, and the signs that do slip through look like ordinary daily complaints.

8 warning signs of oral cancer you shouldn’t just write off as a mouth sore

Many of these warning signs look like nothing more than everyday mouth irritation that will heal on its own, which is exactly why they get missed.

Why the weight comes back: Your fat cells may hold onto obesity’s memory

A new study points to a stubborn hunger signal in fat tissue that may stay switched on long after the diet ends.

Why you should always look for ‘D3’ on your vitamin supplement

The two forms on the shelf look almost identical, but new research suggests one may quietly work against the other.

8 warning signs of chronic kidney disease most people write off as something else

Your kidneys can quietly lose most of their work before you ever feel anything is wrong, and the signs that do slip through look like ordinary daily complaints.

8 warning signs of oral cancer you shouldn’t just write off as a mouth sore

Many of these warning signs look like nothing more than everyday mouth irritation that will heal on its own, which is exactly why they get missed.